Holy Basil in The Treatment of Dyspepsia

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

December 31, 2026

Conditions
Dyspepsia and Other Specified Disorders of Function of Stomach
Interventions
DRUG

Holy basil extract

"Holy basil extract (Ocimum sanctum) will be provided as an oral capsule formulation. Each capsule contains 300 mg of standardized holy basil extract with defined amounts of active compounds including ursolic acid (≥0.10 mg) and rosmarinic acid (≥0.50 mg). Participants will be instructed to take one capsule once daily for 28 consecutive days.~The capsules will be dispensed in blister packs, with labeling according to clinical trial regulatory requirements. Participants will be asked to record daily intake in a study diary, and compliance."

Trial Locations (1)

10700

Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok Noi

All Listed Sponsors
lead

Mahidol University

OTHER

NCT07175272 - Holy Basil in The Treatment of Dyspepsia | Biotech Hunter | Biotech Hunter